Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
PMID 17474166
Andrea Corona MapLight reports mixed results in Schizophrenia trial In their Phase 2 ZEPHR trial, MapLights novel oral drug for schizophrenia, the Ml/M4 muscarinic agonist ML-007C-MA, successfully hit its primary endpoint but only for the twice-daily version, not the once-daily dose
Understanding these pathways could lead to new treatments for inflammatory diseases and conditions
Regulatory notice for athletes & U.S
You need a prescription to obtain a B12 injection, but they can be safely administered by a doctor or even at home
.png.jpg)
US$ 22.55
US$ 22.31
US$ 28.44
US$ 27.50
US$ 28.43
US$ 23.65
